EcoDrugPlus

Calcium Voltage-Gated Channel Subunit Alpha1 E

Ensembl ID : ENSSDUG00000000475
Gene Symbol: CACNA1E
3 Cross references
213 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 E

Ensembl ID : ENSSDUG00000018484
Gene Symbol: CACNA1E
3 Cross references
207 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 H

Ensembl ID : ENSSDUG00000017433
Gene Symbol: CACNA1H
4 Cross references
208 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 I

Ensembl ID : ENSSDUG00000012300
Gene Symbol: CACNA1I
3 Cross references
183 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSSDUG00000004310
Gene Symbol: CNR1
3 Cross references
150 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSSDUG00000017598
Gene Symbol: CNR1
2 Cross references
134 Possible Orthologues:

Cannabinoid Receptor 2

Ensembl ID : ENSSDUG00000010638
Gene Symbol: CNR2
1 Cross references
191 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSSDUG00000008779
Gene Symbol: CA12
3 Cross references
214 Possible Orthologues:

Carbonic Anhydrase 14

Ensembl ID : ENSSDUG00000006746
Gene Symbol: CA14
3 Cross references
210 Possible Orthologues:

Carbonic Anhydrase 4

Ensembl ID : ENSSDUG00000017377
Gene Symbol: CA4
3 Cross references
212 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSSDUG00000010854
Gene Symbol: LOC111232281
3 Cross references
196 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSSDUG00000019547
Gene Symbol: LOC111217236
3 Cross references
79 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).